# FDA 483 - Eugia Pharma Specialities Limited - November 13, 2019

Source: https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/414d62e8-c6c9-4214-ba53-cc56bdc079d3

> FDA 483 for Eugia Pharma Specialities Limited on November 13, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eugia Pharma Specialities Limited
- Inspection Date: 2019-11-13
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I

## Related Documents

- [483 - 2018-12-14](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/05698986-cd1a-4aaa-9f96-85f99153f0a4)
- [483 - 2017-04-28](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/2e2978c9-6a02-4cce-a0c4-1163d3a8b660)
- [483 - 2026-01-27](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/e061c5af-789c-4a1d-bc2f-3e5a527a7a7a)
- [483 - 2018-02-20](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/a79eaef1-d0d8-477c-9fe3-124b321d92aa)
- [483 - 2026-02-06](https://www.globalkeysolutions.net/records/483/eugia-pharma-specialities-limited/4de3a2c8-d7e4-4c76-b46e-713f1d206518)

## Related Officers

- [Dipesh K. Shah](https://www.globalkeysolutions.net/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)
- [Freddy Ortiz Colon](https://www.globalkeysolutions.net/people/freddy-ortiz-colon/10993029-31ff-44ec-b5c7-75c5ed827e7b)
- [Investigator ](https://www.globalkeysolutions.net/people/marie-buen-bigornia/0d363d83-b630-447d-8766-09c8f85665a7)
- [Thomas J. Arista](https://www.globalkeysolutions.net/people/thomas-j-arista/37905892-3285-4f3f-b4b5-f963df1e59d3)
- [June P. Page](https://www.globalkeysolutions.net/people/june-p-page/3b1ffc71-ce2e-47f5-aefe-87fd5eebc792)

Company: https://www.globalkeysolutions.net/companies/eugia-pharma-specialities-limited/9733456f-3189-4fe6-a4f9-327f0ce92559

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1